Company / Capital Expenditures
TELA Bio, Inc. Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$611.0K
FY2025
5-year range
$167.0K / $872.0K
FY2021-FY2025
Trend
-29.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 7 years, ranging from $62,000 in FY2020 to $872,000 in FY2024.
Based on SEC 10-K filings.
$611,000 in FY2025 with a 5-year CAGR of +58.0%.
Declined from $627,000 to $611,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +54.1%
- 5-Year CAGR
- +58.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +58.0%, indicating consistent growth.
- In FY2025, capital expenditures decreased 29.9% year-over-year.
- Peak capital expenditures was recorded in FY2024.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $611.0K | -29.9% |
| FY2024 | $872.0K | +39.1% |
| FY2023 | $627.0K | +275.4% |
| FY2022 | $167.0K | -15.2% |
| FY2021 | $197.0K | +217.7% |
| FY2020 | $62.0K | -45.6% |
| FY2019 | $114.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026